ClinicalTrials.Veeva

Menu

Correlation of Peak Tidal Inspiratory Flow Measured Before and After Extubation in Adult Patients With Hypoxemia

Rush logo

Rush

Status

Terminated

Conditions

Hypoxemic Respiratory Failure

Treatments

Other: HFNC flow set at 1.33 times of patient peak tidal inspiratory flow
Other: HFNC flow set at 1.67 times of patient peak tidal inspiratory flow
Other: HFNC flow set at patient peak tidal inspiratory flow
Other: HFNC flow set at 2 times of patient peak tidal inspiratory flow

Study type

Interventional

Funder types

Other

Identifiers

NCT04971148
HFNC-Flow-004

Details and patient eligibility

About

In this study, patients who are ready for extubation and indicated for high-flow nasal cannula therapy after extubation will be enrolled, the investigators would measure the patient peak tidal inspiratory flow (PTIF) pre and post extubation to explore the correlation between the two PTIFs. Moreover, different HFNC flows would be applied, to explore the patient response in terms of oxygenation and lung aeration to different flow ratios that matched and are above post-extubation PTIF.

Full description

High-flow nasal cannula (HFNC) oxygen therapy has been shown to improve oxygenation, reduce the need for intubation for patients with acute hypoxemic respiratory failure (AHRF) and avoid reintubation for post-extubation patients who had high-risk factors. HFNC refers to the delivery of gas at flows that exceed the patient peak inspiratory flow during tidal breathing, However, patient peak tidal inspiratory flow (PTIF) is found to vary greatly among different patients, from 20 to 50 L/min, making it difficult to properly set HFNC in a way to achieve the desired effects. In two recently published studies in intubated patients, PTIF varied from 25-65 L/min or 40-80 L/min, thus this study aims to investigate the correlation between pre-extubation PTIF in different modalities of SBT and post-extubation PTIF for adult patients, who are indicated to use HFNC immediately after extubation. In addition, the investigators aim to explore the patient response in terms of oxygenation and lung aeration to different flow ratios that matched and are above post-extubation PTIF.

Enrollment

5 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult intubated patients aged between 18 to 90 years
  • Pass spontaneous breathing trial and receive the order to be extubated
  • Have at least one of the indications to use HFNC after extubation

Exclusion criteria

  • Need to use inhaled epoprostenol via HFNC
  • Pregnant
  • Unable to use resuscitation mask, such as facial trauma, claustrophobia
  • Non-English speaker
  • Inability to verbally communicate
  • Using extracorporeal membrane oxygenation (ECMO)
  • Hemodynamically unstable
  • Difficult airway

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

5 participants in 4 patient groups

HFNC flow set at patient peak tidal inspiratory flow
Active Comparator group
Description:
HFNC flow will be set at the level that matches patient peak tidal inspiratory flow
Treatment:
Other: HFNC flow set at patient peak tidal inspiratory flow
HFNC flow set at 1.33 times of patient peak tidal inspiratory flow
Experimental group
Description:
HFNC flow will be set at the level that is 1.33 times of patient peak tidal inspiratory flow
Treatment:
Other: HFNC flow set at 1.33 times of patient peak tidal inspiratory flow
HFNC flow set at 1.67 times of patient peak tidal inspiratory flow
Experimental group
Description:
HFNC flow will be set at the level that is 1.67 times of patient peak tidal inspiratory flow
Treatment:
Other: HFNC flow set at 1.67 times of patient peak tidal inspiratory flow
HFNC flow set at 2 times of patient peak tidal inspiratory flow
Experimental group
Description:
HFNC flow will be set at the level that is 2 times of patient peak tidal inspiratory flow
Treatment:
Other: HFNC flow set at 2 times of patient peak tidal inspiratory flow

Trial contacts and locations

2

Loading...

Central trial contact

Jie Li, PhD; Brady Scott, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems